Managing the cognitive effects of brain tumor radiation therapy

Current Treatment Options in Oncology

Volumn 7, Issue 6, 2006, Pages 517-523

  Butler Jr , Jerome M ^a   Rapp, Stephen R ^a   Shaw, Edward G ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; COTRIMOXAZOLE; DEXAMETHASONE; DONEPEZIL; FLUCONAZOLE; GINKGO BILOBA EXTRACT; HYDROCORTISONE; INSULIN; MANNITOL; METHYLPHENIDATE; OXYGEN; PLACEBO; RANITIDINE; TEMOZOLOMIDE; WARFARIN; XIPAMIDE;

ANXIETY; ARTHRALGIA; ASTROCYTE; BEHAVIOR THERAPY; BODY WEIGHT DISORDER; BRAIN CELL; BRAIN INJURY; BRAIN NERVE CELL; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CUSHINGOID SYNDROME; DISEASE COURSE; DISEASE DURATION; DRUG DOSE REGIMEN; ENDOTHELIUM CELL; ERYTHEMA; FACE EDEMA; FATIGUE; GASTRITIS; HAIR LOSS; HUMAN; HYPERBARIC OXYGEN; HYPERGLYCEMIA; INCIDENCE; INFLAMMATION; INSOMNIA; MEDICAL RESEARCH; MICROGLIA; MOOD CHANGE; MUSCLE ATROPHY; NEURAL STEM CELL; OBESITY; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOGENESIS; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE CARE; PREVALENCE; QUALITY OF LIFE; RADIATION EXPOSURE; RADIATION NECROSIS; REHABILITATION CARE; REVIEW; SOMNOLENCE; STRIA; TACHYCARDIA; THRUSH; TUMOR LOCALIZATION;

BRAIN NEOPLASMS; COGNITION DISORDERS; HUMANS; RADIATION INJURIES; RADIOTHERAPY;

EID: 33750723795     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-006-0026-5     Document Type: Review

References (39)

1. Shaw EG: Central nervous system overview. In Clinical Radiation Oncology. Edited by Gunderson LL, Tepper JE. Philadelphia: Churchill-Livingstone; 2000:314-335.
2. Gleason J, Case D, Rapp S, et al.: Symptom clusters in newly diagnosed brain tumor patients. Abstract presented at the 42nd Annual Meeting of the American Society of Clinical Oncology. Atlanta, GA; June 2-6, 2006.
3. Saconn PA, Ip E, Rapp S, et al.: Symptom clusters in irradiated brain tumor survivors. Abstract presented at the 42nd Annual Meeting of the American Society of Clinical Oncology. Atlanta, GA; June 2-6, 2006.
4. Dodd MJ, Miaskowski C, Lee KA: Occurrence of symptom clusters. J Natl Cancer Inst Monogr 2004, 32:76-78.
5. Dodd MJ, Miaskowski C, Paul SM: Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 2001, 28:465-470.
6. Weitzner MA, Meyers CA, Valentine AD: Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment. J Neuropsychiatry Clin Neurosci 1995, 7:347-350.
7. Mulhern RK, Khan RB, Kaplan S, et al.: Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 2004, 22:4795-4803.
8. Butler J, Case D, Atkins J, et al.: A phase III double blind placebo controlled prospective randomized clinical trial of effect of d-throe-methylphenidate HCL (d-MPH) on quality of life in brain tumor patients receiving radiation therapy [abstract]. Int J Radiat Oncol Biol Phys 2005, 63(Supp 1):80.
9. Weitzner MA, Meyers CA, Gelke CK et al.: The Functional Assessment of Cancer Therapy (FACT) scale: development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 1995, 75:1151-1161.
10. Yellen SB, Cella DF, Webster K et al.: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997, 13:63-67.
11. Halperin EC, Constine LS, Tarbell NJ, Kun LE: Pediatric Radiation Oncology, edn 2. New York Raven Press; 1994.
12. Wen PY, Marks PW: Medical management of patients with brain tumors. Curr Opin Oncol 2002, 14:299-307.
13. Stupp R, Dietrich PY, Ostermann Kraljevic S, et al.: Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 2002, 20:1375-1382.
14. Forsyth PA, Kelly PJ, Casano TL, et al.: Radiation necrosis or glioma recurrence: is computer assisted stereotactic biopsy useful? J Neurosurg 1995, 82:436-444.
15. Liu CY, Yim BY, Wozniak AJ: Anticoagulation therapy for radiation-induced myelopathy. Ann Pharmacother 2001, 35:188-191.
16. Leber KA, Eder HG, Kovac H, et al.: Treatment of cerebral radionecrosis by hyperbaric oxygen therapy. Stereotact Funct Neurosurg 1998, 70(Suppl 1):229-236.
17. Kim JH, Brown SL, Kolozsvary A, et al.: Modification of radiation injury by ramipril, inhibitor of the angiotensin-converting enzyme, on optic neuropathy in the rat. Radiat Res 2004, 161:137-142.
18. Laukkanen E, Klonof H, Allan B, et al.: The role of prophylactic brain irradiation in limited stage small-cell lung cancer: clinical, neuropsychologic, and CT sequelae. Int J Radiat Oncol Biol Phys 1988, 14:1109-1117.
19. Johnson BE, Becker B, Goff WB, et al.: Neurologic, neuropsychologic, and computed cranial tomography scan abnormalities in 2- to 10-year survivors of small-cell lung cancer. J Clin Oncol 1985, 3:1659-1667.
20. Halberg F, Kramer J, Moore I, et al.: Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia. Int J Radiat Oncol Biol Phys 1991, 11:13-16.
21. DeAngelis LM, Delattre J, Posner JB: Radiation-induced dementia in patients cured of metastases. Neurology 1989, 39:789-796.
22. Frytak S, Shaw JN, O'Neill BP, et al.: Leuko-encephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation. Am J Clin Oncol 1989, 12:27-33.
23. Silber J, Radcliffe J, Peckham V, et al.: Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score. J Clin Oncol 1992, 10:1390-1396.
24. Ris M, Noll R: Long-term neurobehavioral outcome in pediatric brain-tumor patients: review and methodological critique. J Clin Exp Neuropsychol 1994, 16:21-42.
25. Mulhern R, Hancock J, Fairclough D, Kun L: Neuropsychological status of children treated for brain tumors: a critical review and integrative analysis. Med Pediat Oncol 1992, 20:181-191.
26. Mulhern R, Fairclough D, Ochs D: A prospective comparison of neuropsychological performance of children surviving leukemia who received 18Gy, 24Gy, or no cranial irradiation. J Clin Oncol 1991, 9:1348-1356.
27. Ochs J, Mulhern R, Fairclough D, et al.: Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study. J Clin Oncol 1991, 9:145-151.
28. Shaw EG, Rosdhal R, D'Agostino RB Jr, et al.: A phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 2006, 24:1415-1420.
29. McNair DM, Lorr M, Droppleman LF: Profile of Mood States Manual. San Diego: Educational and Industrial Testing Service; 1992.
30. Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958, 8:271-276.
31. Wechsler D: Wechsler Adult Intelligence Scale-Revised Manual. New York: Psychological Corporation; 1981.
32. Fastenau PS, Denburg NL, Hufford BJ: Adult norms for the Rey-Osterrieth Complex Figure Test and for supplemental recognition and matching trials from the Extended Complex Figure Test. Clin Neuropsychol 1999, 13:30-47.
33. Kaplan EF, Goodglass H, Weintraub S: The Boston Naming Test. Boston: E Kaplan & H Goodglass; 1978.
34. Benton AL, Hamsher K: Multilingual Aphasia Examination. Iowa City: AJA Associates; 1983.
35. Delis DC, Kramer JH, Kaplan E, Ober BA: California Verbal Learning Test-Research Edition. New York: The Psychological Corp.; 1987.
36. Bryson HM, Benfield P: Donepezil. Drugs Aging 1997, 10:234-243.
37. Rogers SL, Doody RS, Mohs RC, Friedhoff LT; the Donepezil Study Group: Donepezil improves cognition and global function in Alzheimer's disease. Arch Int Med 1998, 158:1021-1031.
38. Rogers SL, Farlow MR, Doody RS, et al.: The Donepezil Study Group: a 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 1998, 50:136-145.
39. Le Bars PL, Katz MM, Berman N, et al.: A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. JAMA 1997, 278:1327-1332.